血管新生モジュレーターの世界市場（～2026年）

• 英文タイトル：Global Angiogenesis Modulators Market Insights and Forecast to 2026

• レポートコード：MRC2-11QY02438 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、117ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ
Enterprise License	￥1,154,400 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料は血管新生モジュレーターのグローバル市場について調査・分析したレポートです。種類別（血管新生阻害剤、血管新生刺激剤、アンギオゲニン、その他）市場規模、用途別（乳がん、結腸直腸がん、肺がん、前立腺がん、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別血管新生モジュレーターの競争状況、市場シェア ・世界の血管新生モジュレーター市場：種類別市場規模 2015年-2020年（血管新生阻害剤、血管新生刺激剤、アンギオゲニン、その他） ・世界の血管新生モジュレーター市場：種類別市場規模予測 2021年-2026年（血管新生阻害剤、血管新生刺激剤、アンギオゲニン、その他） ・世界の血管新生モジュレーター市場：用途別市場規模 2015年-2020年（乳がん、結腸直腸がん、肺がん、前立腺がん、その他） ・世界の血管新生モジュレーター市場：用途別市場規模予測 2021年-2026年（乳がん、結腸直腸がん、肺がん、前立腺がん、その他） ・北米の血管新生モジュレーター市場分析：米国、カナダ ・ヨーロッパの血管新生モジュレーター市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの血管新生モジュレーター市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の血管新生モジュレーター市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの血管新生モジュレーター市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Celgene Corporation (USA)、Eisai (Japan)、Amgen, Inc. (USA)、Genentech, Inc. (USA)、GlaxoSmithKline plc (UK)、Bayer Pharma AG (Germany)、Bionomics Ltd. (Australia)、CASI Pharmaceuticals, Inc. (USA)、AstraZeneca plc (UK)、Eli Lilly and Company (USA)、F.Hoffmann-La Roche AG (Switzerland) ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論

Market Analysis and Insights: Global Angiogenesis Modulators Market
The global Angiogenesis Modulators market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.

Global Angiogenesis Modulators Scope and Market Size
Angiogenesis Modulators market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Angiogenesis Modulators market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

Segment by Type, the Angiogenesis Modulators market is segmented into
Angiogenesis Inhibitors
Angiogenesis Stimulators
Angiogenin
Others

Segment by Application, the Angiogenesis Modulators market is segmented into
Breast Cancer
Colorectal Cancer
Lung Cancer
Prostate Cancer
Others

Regional and Country-level Analysis
The Angiogenesis Modulators market is analysed and market size information is provided by regions (countries).
The key regions covered in the Angiogenesis Modulators market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Angiogenesis Modulators Market Share Analysis
Angiogenesis Modulators market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Angiogenesis Modulators business, the date to enter into the Angiogenesis Modulators market, Angiogenesis Modulators product introduction, recent developments, etc.

The major vendors covered:
Celgene Corporation (USA)
Eisai (Japan)
Amgen, Inc. (USA)
Genentech, Inc. (USA)
GlaxoSmithKline plc (UK)
Bayer Pharma AG (Germany)
Bionomics Ltd. (Australia)
CASI Pharmaceuticals, Inc. (USA)
AstraZeneca plc (UK)
Eli Lilly and Company (USA)
F.Hoffmann-La Roche AG (Switzerland)

レポート目次

---

1 Study Coverage
1.1 Angiogenesis Modulators Product Introduction
1.2 Market Segments
1.3 Key Angiogenesis Modulators Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Angiogenesis Modulators Market Size Growth Rate by Type
1.4.2 Angiogenesis Inhibitors
1.4.3 Angiogenesis Stimulators
1.4.4 Angiogenin
1.4.5 Others
1.5 Market by Application
1.5.1 Global Angiogenesis Modulators Market Size Growth Rate by Application
1.5.2 Breast Cancer
1.5.3 Colorectal Cancer
1.5.4 Lung Cancer
1.5.5 Prostate Cancer
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Angiogenesis Modulators Market Size, Estimates and Forecasts
2.1.1 Global Angiogenesis Modulators Revenue 2015-2026
2.1.2 Global Angiogenesis Modulators Sales 2015-2026
2.2 Global Angiogenesis Modulators, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Angiogenesis Modulators Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Angiogenesis Modulators Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Angiogenesis Modulators Competitor Landscape by Players
3.1 Angiogenesis Modulators Sales by Manufacturers
3.1.1 Angiogenesis Modulators Sales by Manufacturers (2015-2020)
3.1.2 Angiogenesis Modulators Sales Market Share by Manufacturers (2015-2020)
3.2 Angiogenesis Modulators Revenue by Manufacturers
3.2.1 Angiogenesis Modulators Revenue by Manufacturers (2015-2020)
3.2.2 Angiogenesis Modulators Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Angiogenesis Modulators Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Angiogenesis Modulators Revenue in 2019
3.2.5 Global Angiogenesis Modulators Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Angiogenesis Modulators Price by Manufacturers
3.4 Angiogenesis Modulators Manufacturing Base Distribution, Product Types
3.4.1 Angiogenesis Modulators Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Angiogenesis Modulators Product Type
3.4.3 Date of International Manufacturers Enter into Angiogenesis Modulators Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)
4.1 Global Angiogenesis Modulators Market Size by Type (2015-2020)
4.1.1 Global Angiogenesis Modulators Sales by Type (2015-2020)
4.1.2 Global Angiogenesis Modulators Revenue by Type (2015-2020)
4.1.3 Angiogenesis Modulators Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Angiogenesis Modulators Market Size Forecast by Type (2021-2026)
4.2.1 Global Angiogenesis Modulators Sales Forecast by Type (2021-2026)
4.2.2 Global Angiogenesis Modulators Revenue Forecast by Type (2021-2026)
4.2.3 Angiogenesis Modulators Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Angiogenesis Modulators Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)
5.1 Global Angiogenesis Modulators Market Size by Application (2015-2020)
5.1.1 Global Angiogenesis Modulators Sales by Application (2015-2020)
5.1.2 Global Angiogenesis Modulators Revenue by Application (2015-2020)
5.1.3 Angiogenesis Modulators Price by Application (2015-2020)
5.2 Angiogenesis Modulators Market Size Forecast by Application (2021-2026)
5.2.1 Global Angiogenesis Modulators Sales Forecast by Application (2021-2026)
5.2.2 Global Angiogenesis Modulators Revenue Forecast by Application (2021-2026)
5.2.3 Global Angiogenesis Modulators Price Forecast by Application (2021-2026)

6 North America
6.1 North America Angiogenesis Modulators by Country
6.1.1 North America Angiogenesis Modulators Sales by Country
6.1.2 North America Angiogenesis Modulators Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Angiogenesis Modulators Market Facts & Figures by Type
6.3 North America Angiogenesis Modulators Market Facts & Figures by Application

7 Europe
7.1 Europe Angiogenesis Modulators by Country
7.1.1 Europe Angiogenesis Modulators Sales by Country
7.1.2 Europe Angiogenesis Modulators Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Angiogenesis Modulators Market Facts & Figures by Type
7.3 Europe Angiogenesis Modulators Market Facts & Figures by Application

8 Asia Pacific
8.1 Asia Pacific Angiogenesis Modulators by Region
8.1.1 Asia Pacific Angiogenesis Modulators Sales by Region
8.1.2 Asia Pacific Angiogenesis Modulators Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Angiogenesis Modulators Market Facts & Figures by Type
8.3 Asia Pacific Angiogenesis Modulators Market Facts & Figures by Application

9 Latin America
9.1 Latin America Angiogenesis Modulators by Country
9.1.1 Latin America Angiogenesis Modulators Sales by Country
9.1.2 Latin America Angiogenesis Modulators Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Angiogenesis Modulators Market Facts & Figures by Type
9.3 Central & South America Angiogenesis Modulators Market Facts & Figures by Application

10 Middle East and Africa
10.1 Middle East and Africa Angiogenesis Modulators by Country
10.1.1 Middle East and Africa Angiogenesis Modulators Sales by Country
10.1.2 Middle East and Africa Angiogenesis Modulators Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Angiogenesis Modulators Market Facts & Figures by Type
10.3 Middle East and Africa Angiogenesis Modulators Market Facts & Figures by Application

11 Company Profiles
11.1 Celgene Corporation (USA)
11.1.1 Celgene Corporation (USA) Corporation Information
11.1.2 Celgene Corporation (USA) Description and Business Overview
11.1.3 Celgene Corporation (USA) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Celgene Corporation (USA) Angiogenesis Modulators Products Offered
11.1.5 Celgene Corporation (USA) Related Developments
11.2 Eisai (Japan)
11.2.1 Eisai (Japan) Corporation Information
11.2.2 Eisai (Japan) Description and Business Overview
11.2.3 Eisai (Japan) Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Eisai (Japan) Angiogenesis Modulators Products Offered
11.2.5 Eisai (Japan) Related Developments
11.3 Amgen, Inc. (USA)
11.3.1 Amgen, Inc. (USA) Corporation Information
11.3.2 Amgen, Inc. (USA) Description and Business Overview
11.3.3 Amgen, Inc. (USA) Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Amgen, Inc. (USA) Angiogenesis Modulators Products Offered
11.3.5 Amgen, Inc. (USA) Related Developments
11.4 Genentech, Inc. (USA)
11.4.1 Genentech, Inc. (USA) Corporation Information
11.4.2 Genentech, Inc. (USA) Description and Business Overview
11.4.3 Genentech, Inc. (USA) Sales, Revenue and Gross Margin (2015-2020)
11.4.4 Genentech, Inc. (USA) Angiogenesis Modulators Products Offered
11.4.5 Genentech, Inc. (USA) Related Developments
11.5 GlaxoSmithKline plc (UK)
11.5.1 GlaxoSmithKline plc (UK) Corporation Information
11.5.2 GlaxoSmithKline plc (UK) Description and Business Overview
11.5.3 GlaxoSmithKline plc (UK) Sales, Revenue and Gross Margin (2015-2020)
11.5.4 GlaxoSmithKline plc (UK) Angiogenesis Modulators Products Offered
11.5.5 GlaxoSmithKline plc (UK) Related Developments
11.6 Bayer Pharma AG (Germany)
11.6.1 Bayer Pharma AG (Germany) Corporation Information
11.6.2 Bayer Pharma AG (Germany) Description and Business Overview
11.6.3 Bayer Pharma AG (Germany) Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Bayer Pharma AG (Germany) Angiogenesis Modulators Products Offered
11.6.5 Bayer Pharma AG (Germany) Related Developments
11.7 Bionomics Ltd. (Australia)
11.7.1 Bionomics Ltd. (Australia) Corporation Information
11.7.2 Bionomics Ltd. (Australia) Description and Business Overview
11.7.3 Bionomics Ltd. (Australia) Sales, Revenue and Gross Margin (2015-2020)
11.7.4 Bionomics Ltd. (Australia) Angiogenesis Modulators Products Offered
11.7.5 Bionomics Ltd. (Australia) Related Developments
11.8 CASI Pharmaceuticals, Inc. (USA)
11.8.1 CASI Pharmaceuticals, Inc. (USA) Corporation Information
11.8.2 CASI Pharmaceuticals, Inc. (USA) Description and Business Overview
11.8.3 CASI Pharmaceuticals, Inc. (USA) Sales, Revenue and Gross Margin (2015-2020)
11.8.4 CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Products Offered
11.8.5 CASI Pharmaceuticals, Inc. (USA) Related Developments
11.9 AstraZeneca plc (UK)
11.9.1 AstraZeneca plc (UK) Corporation Information
11.9.2 AstraZeneca plc (UK) Description and Business Overview
11.9.3 AstraZeneca plc (UK) Sales, Revenue and Gross Margin (2015-2020)
11.9.4 AstraZeneca plc (UK) Angiogenesis Modulators Products Offered
11.9.5 AstraZeneca plc (UK) Related Developments
11.10 Eli Lilly and Company (USA)
11.10.1 Eli Lilly and Company (USA) Corporation Information
11.10.2 Eli Lilly and Company (USA) Description and Business Overview
11.10.3 Eli Lilly and Company (USA) Sales, Revenue and Gross Margin (2015-2020)
11.10.4 Eli Lilly and Company (USA) Angiogenesis Modulators Products Offered
11.10.5 Eli Lilly and Company (USA) Related Developments
11.1 Celgene Corporation (USA)
11.1.1 Celgene Corporation (USA) Corporation Information
11.1.2 Celgene Corporation (USA) Description and Business Overview
11.1.3 Celgene Corporation (USA) Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Celgene Corporation (USA) Angiogenesis Modulators Products Offered
11.1.5 Celgene Corporation (USA) Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Angiogenesis Modulators Market Estimates and Projections by Region
12.1.1 Global Angiogenesis Modulators Sales Forecast by Regions 2021-2026
12.1.2 Global Angiogenesis Modulators Revenue Forecast by Regions 2021-2026
12.2 North America Angiogenesis Modulators Market Size Forecast (2021-2026)
12.2.1 North America: Angiogenesis Modulators Sales Forecast (2021-2026)
12.2.2 North America: Angiogenesis Modulators Revenue Forecast (2021-2026)
12.2.3 North America: Angiogenesis Modulators Market Size Forecast by Country (2021-2026)
12.3 Europe Angiogenesis Modulators Market Size Forecast (2021-2026)
12.3.1 Europe: Angiogenesis Modulators Sales Forecast (2021-2026)
12.3.2 Europe: Angiogenesis Modulators Revenue Forecast (2021-2026)
12.3.3 Europe: Angiogenesis Modulators Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Angiogenesis Modulators Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Angiogenesis Modulators Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Angiogenesis Modulators Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Angiogenesis Modulators Market Size Forecast by Region (2021-2026)
12.5 Latin America Angiogenesis Modulators Market Size Forecast (2021-2026)
12.5.1 Latin America: Angiogenesis Modulators Sales Forecast (2021-2026)
12.5.2 Latin America: Angiogenesis Modulators Revenue Forecast (2021-2026)
12.5.3 Latin America: Angiogenesis Modulators Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Angiogenesis Modulators Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Angiogenesis Modulators Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Angiogenesis Modulators Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Angiogenesis Modulators Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Angiogenesis Modulators Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Angiogenesis Modulators Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables
Table 1. Angiogenesis Modulators Market Segments
Table 2. Ranking of Global Top Angiogenesis Modulators Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Angiogenesis Modulators Market Size Growth Rate by Type 2020-2026 (K MT) & (US$ Million)
Table 4. Major Manufacturers of Angiogenesis Inhibitors
Table 5. Major Manufacturers of Angiogenesis Stimulators
Table 6. Major Manufacturers of Angiogenin
Table 7. Major Manufacturers of Others
Table 8. Global Angiogenesis Modulators Market Size Growth Rate by Application 2020-2026 (K MT)
Table 9. Global Angiogenesis Modulators Market Size by Region (K MT) & (US$ Million): 2020 VS 2026
Table 10. Global Angiogenesis Modulators Sales by Regions 2015-2020 (K MT)
Table 11. Global Angiogenesis Modulators Sales Market Share by Regions (2015-2020)
Table 12. Global Angiogenesis Modulators Revenue by Regions 2015-2020 (US$ Million)
Table 13. Global Angiogenesis Modulators Sales by Manufacturers (2015-2020) (K MT)
Table 14. Global Angiogenesis Modulators Sales Share by Manufacturers (2015-2020)
Table 15. Global Angiogenesis Modulators Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 16. Global Angiogenesis Modulators by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Angiogenesis Modulators as of 2019)
Table 17. Angiogenesis Modulators Revenue by Manufacturers (2015-2020) (US$ Million)
Table 18. Angiogenesis Modulators Revenue Share by Manufacturers (2015-2020)
Table 19. Key Manufacturers Angiogenesis Modulators Price (2015-2020) (USD/MT)
Table 20. Angiogenesis Modulators Manufacturers Manufacturing Base Distribution and Headquarters
Table 21. Manufacturers Angiogenesis Modulators Product Type
Table 22. Date of International Manufacturers Enter into Angiogenesis Modulators Market
Table 23. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 24. Global Angiogenesis Modulators Sales by Type (2015-2020) (K MT)
Table 25. Global Angiogenesis Modulators Sales Share by Type (2015-2020)
Table 26. Global Angiogenesis Modulators Revenue by Type (2015-2020) (US$ Million)
Table 27. Global Angiogenesis Modulators Revenue Share by Type (2015-2020)
Table 28. Angiogenesis Modulators Average Selling Price (ASP) by Type 2015-2020 (USD/MT)
Table 29. Global Angiogenesis Modulators Sales by Application (2015-2020) (K MT)
Table 30. Global Angiogenesis Modulators Sales Share by Application (2015-2020)
Table 31. North America Angiogenesis Modulators Sales by Country (2015-2020) (K MT)
Table 32. North America Angiogenesis Modulators Sales Market Share by Country (2015-2020)
Table 33. North America Angiogenesis Modulators Revenue by Country (2015-2020) (US$ Million)
Table 34. North America Angiogenesis Modulators Revenue Market Share by Country (2015-2020)
Table 35. North America Angiogenesis Modulators Sales by Type (2015-2020) (K MT)
Table 36. North America Angiogenesis Modulators Sales Market Share by Type (2015-2020)
Table 37. North America Angiogenesis Modulators Sales by Application (2015-2020) (K MT)
Table 38. North America Angiogenesis Modulators Sales Market Share by Application (2015-2020)
Table 39. Europe Angiogenesis Modulators Sales by Country (2015-2020) (K MT)
Table 40. Europe Angiogenesis Modulators Sales Market Share by Country (2015-2020)
Table 41. Europe Angiogenesis Modulators Revenue by Country (2015-2020) (US$ Million)
Table 42. Europe Angiogenesis Modulators Revenue Market Share by Country (2015-2020)
Table 43. Europe Angiogenesis Modulators Sales by Type (2015-2020) (K MT)
Table 44. Europe Angiogenesis Modulators Sales Market Share by Type (2015-2020)
Table 45. Europe Angiogenesis Modulators Sales by Application (2015-2020) (K MT)
Table 46. Europe Angiogenesis Modulators Sales Market Share by Application (2015-2020)
Table 47. Asia Pacific Angiogenesis Modulators Sales by Region (2015-2020) (K MT)
Table 48. Asia Pacific Angiogenesis Modulators Sales Market Share by Region (2015-2020)
Table 49. Asia Pacific Angiogenesis Modulators Revenue by Region (2015-2020) (US$ Million)
Table 50. Asia Pacific Angiogenesis Modulators Revenue Market Share by Region (2015-2020)
Table 51. Asia Pacific Angiogenesis Modulators Sales by Type (2015-2020) (K MT)
Table 52. Asia Pacific Angiogenesis Modulators Sales Market Share by Type (2015-2020)
Table 53. Asia Pacific Angiogenesis Modulators Sales by Application (2015-2020) (K MT)
Table 54. Asia Pacific Angiogenesis Modulators Sales Market Share by Application (2015-2020)
Table 55. Latin America Angiogenesis Modulators Sales by Country (2015-2020) (K MT)
Table 56. Latin America Angiogenesis Modulators Sales Market Share by Country (2015-2020)
Table 57. Latin Americaa Angiogenesis Modulators Revenue by Country (2015-2020) (US$ Million)
Table 58. Latin America Angiogenesis Modulators Revenue Market Share by Country (2015-2020)
Table 59. Latin America Angiogenesis Modulators Sales by Type (2015-2020) (K MT)
Table 60. Latin America Angiogenesis Modulators Sales Market Share by Type (2015-2020)
Table 61. Latin America Angiogenesis Modulators Sales by Application (2015-2020) (K MT)
Table 62. Latin America Angiogenesis Modulators Sales Market Share by Application (2015-2020)
Table 63. Middle East and Africa Angiogenesis Modulators Sales by Country (2015-2020) (K MT)
Table 64. Middle East and Africa Angiogenesis Modulators Sales Market Share by Country (2015-2020)
Table 65. Middle East and Africa Angiogenesis Modulators Revenue by Country (2015-2020) (US$ Million)
Table 66. Middle East and Africa Angiogenesis Modulators Revenue Market Share by Country (2015-2020)
Table 67. Middle East and Africa Angiogenesis Modulators Sales by Type (2015-2020) (K MT)
Table 68. Middle East and Africa Angiogenesis Modulators Sales Market Share by Type (2015-2020)
Table 69. Middle East and Africa Angiogenesis Modulators Sales by Application (2015-2020) (K MT)
Table 70. Middle East and Africa Angiogenesis Modulators Sales Market Share by Application (2015-2020)
Table 71. Celgene Corporation (USA) Corporation Information
Table 72. Celgene Corporation (USA) Description and Major Businesses
Table 73. Celgene Corporation (USA) Angiogenesis Modulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 74. Celgene Corporation (USA) Product
Table 75. Celgene Corporation (USA) Recent Development
Table 76. Eisai (Japan) Corporation Information
Table 77. Eisai (Japan) Description and Major Businesses
Table 78. Eisai (Japan) Angiogenesis Modulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 79. Eisai (Japan) Product
Table 80. Eisai (Japan) Recent Development
Table 81. Amgen, Inc. (USA) Corporation Information
Table 82. Amgen, Inc. (USA) Description and Major Businesses
Table 83. Amgen, Inc. (USA) Angiogenesis Modulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 84. Amgen, Inc. (USA) Product
Table 85. Amgen, Inc. (USA) Recent Development
Table 86. Genentech, Inc. (USA) Corporation Information
Table 87. Genentech, Inc. (USA) Description and Major Businesses
Table 88. Genentech, Inc. (USA) Angiogenesis Modulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 89. Genentech, Inc. (USA) Product
Table 90. Genentech, Inc. (USA) Recent Development
Table 91. GlaxoSmithKline plc (UK) Corporation Information
Table 92. GlaxoSmithKline plc (UK) Description and Major Businesses
Table 93. GlaxoSmithKline plc (UK) Angiogenesis Modulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 94. GlaxoSmithKline plc (UK) Product
Table 95. GlaxoSmithKline plc (UK) Recent Development
Table 96. Bayer Pharma AG (Germany) Corporation Information
Table 97. Bayer Pharma AG (Germany) Description and Major Businesses
Table 98. Bayer Pharma AG (Germany) Angiogenesis Modulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 99. Bayer Pharma AG (Germany) Product
Table 100. Bayer Pharma AG (Germany) Recent Development
Table 101. Bionomics Ltd. (Australia) Corporation Information
Table 102. Bionomics Ltd. (Australia) Description and Major Businesses
Table 103. Bionomics Ltd. (Australia) Angiogenesis Modulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 104. Bionomics Ltd. (Australia) Product
Table 105. Bionomics Ltd. (Australia) Recent Development
Table 106. CASI Pharmaceuticals, Inc. (USA) Corporation Information
Table 107. CASI Pharmaceuticals, Inc. (USA) Description and Major Businesses
Table 108. CASI Pharmaceuticals, Inc. (USA) Angiogenesis Modulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 109. CASI Pharmaceuticals, Inc. (USA) Product
Table 110. CASI Pharmaceuticals, Inc. (USA) Recent Development
Table 111. AstraZeneca plc (UK) Corporation Information
Table 112. AstraZeneca plc (UK) Description and Major Businesses
Table 113. AstraZeneca plc (UK) Angiogenesis Modulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 114. AstraZeneca plc (UK) Product
Table 115. AstraZeneca plc (UK) Recent Development
Table 116. Eli Lilly and Company (USA) Corporation Information
Table 117. Eli Lilly and Company (USA) Description and Major Businesses
Table 118. Eli Lilly and Company (USA) Angiogenesis Modulators Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 119. Eli Lilly and Company (USA) Product
Table 120. Eli Lilly and Company (USA) Recent Development
Table 121. F.Hoffmann-La Roche AG (Switzerland) Corporation Information
Table 122. F.Hoffmann-La Roche AG (Switzerland) Description and Major Businesses
Table 123. F.Hoffmann-La Roche AG (Switzerland) Angiogenesis Modulators Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2015-2020)
Table 124. F.Hoffmann-La Roche AG (Switzerland) Product
Table 125. F.Hoffmann-La Roche AG (Switzerland) Recent Development
Table 126. Global Angiogenesis Modulators Sales Forecast by Regions (2021-2026) (K MT)
Table 127. Global Angiogenesis Modulators Sales Market Share Forecast by Regions (2021-2026)
Table 128. Global Angiogenesis Modulators Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 129. Global Angiogenesis Modulators Revenue Market Share Forecast by Regions (2021-2026)
Table 130. North America: Angiogenesis Modulators Sales Forecast by Country (2021-2026) (K MT)
Table 131. North America: Angiogenesis Modulators Revenue Forecast by Country (2021-2026) (US$ Million)
Table 132. Europe: Angiogenesis Modulators Sales Forecast by Country (2021-2026) (K MT)
Table 133. Europe: Angiogenesis Modulators Revenue Forecast by Country (2021-2026) (US$ Million)
Table 134. Asia Pacific: Angiogenesis Modulators Sales Forecast by Region (2021-2026) (K MT)
Table 135. Asia Pacific: Angiogenesis Modulators Revenue Forecast by Region (2021-2026) (US$ Million)
Table 136. Latin America: Angiogenesis Modulators Sales Forecast by Country (2021-2026) (K MT)
Table 137. Latin America: Angiogenesis Modulators Revenue Forecast by Country (2021-2026) (US$ Million)
Table 138. Middle East and Africa: Angiogenesis Modulators Sales Forecast by Country (2021-2026) (K MT)
Table 139. Middle East and Africa: Angiogenesis Modulators Revenue Forecast by Country (2021-2026) (US$ Million)
Table 140. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 141. Key Challenges
Table 142. Market Risks
Table 143. Main Points Interviewed from Key Angiogenesis Modulators Players
Table 144. Angiogenesis Modulators Customers List
Table 145. Angiogenesis Modulators Distributors List
Table 146. Research Programs/Design for This Report
Table 147. Key Data Information from Secondary Sources
Table 148. Key Data Information from Primary Sources
List of Figures
Figure 1. Angiogenesis Modulators Product Picture
Figure 2. Global Angiogenesis Modulators Sales Market Share by Type in 2020 & 2026
Figure 3. Angiogenesis Inhibitors Product Picture
Figure 4. Angiogenesis Stimulators Product Picture
Figure 5. Angiogenin Product Picture
Figure 6. Others Product Picture
Figure 7. Global Angiogenesis Modulators Sales Market Share by Application in 2020 & 2026
Figure 8. Breast Cancer
Figure 9. Colorectal Cancer
Figure 10. Lung Cancer
Figure 11. Prostate Cancer
Figure 12. Others
Figure 13. Angiogenesis Modulators Report Years Considered
Figure 14. Global Angiogenesis Modulators Market Size 2015-2026 (US$ Million)
Figure 15. Global Angiogenesis Modulators Sales 2015-2026 (K MT)
Figure 16. Global Angiogenesis Modulators Market Size Market Share by Region: 2020 Versus 2026
Figure 17. Global Angiogenesis Modulators Sales Market Share by Region (2015-2020)
Figure 18. Global Angiogenesis Modulators Sales Market Share by Region in 2019
Figure 19. Global Angiogenesis Modulators Revenue Market Share by Region (2015-2020)
Figure 20. Global Angiogenesis Modulators Revenue Market Share by Region in 2019
Figure 21. Global Angiogenesis Modulators Sales Share by Manufacturer in 2019
Figure 22. The Top 10 and 5 Players Market Share by Angiogenesis Modulators Revenue in 2019
Figure 23. Angiogenesis Modulators Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 24. Global Angiogenesis Modulators Sales Market Share by Type (2015-2020)
Figure 25. Global Angiogenesis Modulators Sales Market Share by Type in 2019
Figure 26. Global Angiogenesis Modulators Revenue Market Share by Type (2015-2020)
Figure 27. Global Angiogenesis Modulators Revenue Market Share by Type in 2019
Figure 28. Global Angiogenesis Modulators Market Share by Price Range (2015-2020)
Figure 29. Global Angiogenesis Modulators Sales Market Share by Application (2015-2020)
Figure 30. Global Angiogenesis Modulators Sales Market Share by Application in 2019
Figure 31. Global Angiogenesis Modulators Revenue Market Share by Application (2015-2020)
Figure 32. Global Angiogenesis Modulators Revenue Market Share by Application in 2019
Figure 33. North America Angiogenesis Modulators Sales Growth Rate 2015-2020 (K MT)
Figure 34. North America Angiogenesis Modulators Revenue Growth Rate 2015-2020 (US$ Million)
Figure 35. North America Angiogenesis Modulators Sales Market Share by Country in 2019
Figure 36. North America Angiogenesis Modulators Revenue Market Share by Country in 2019
Figure 37. U.S. Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 38. U.S. Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. Canada Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 40. Canada Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. North America Angiogenesis Modulators Market Share by Type in 2019
Figure 42. North America Angiogenesis Modulators Market Share by Application in 2019
Figure 43. Europe Angiogenesis Modulators Sales Growth Rate 2015-2020 (K MT)
Figure 44. Europe Angiogenesis Modulators Revenue Growth Rate 2015-2020 (US$ Million)
Figure 45. Europe Angiogenesis Modulators Sales Market Share by Country in 2019
Figure 46. Europe Angiogenesis Modulators Revenue Market Share by Country in 2019
Figure 47. Germany Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 48. Germany Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. France Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 50. France Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. U.K. Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 52. U.K. Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. Italy Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 54. Italy Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Russia Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 56. Russia Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Europe Angiogenesis Modulators Market Share by Type in 2019
Figure 58. Europe Angiogenesis Modulators Market Share by Application in 2019
Figure 59. Asia Pacific Angiogenesis Modulators Sales Growth Rate 2015-2020 (K MT)
Figure 60. Asia Pacific Angiogenesis Modulators Revenue Growth Rate 2015-2020 (US$ Million)
Figure 61. Asia Pacific Angiogenesis Modulators Sales Market Share by Region in 2019
Figure 62. Asia Pacific Angiogenesis Modulators Revenue Market Share by Region in 2019
Figure 63. China Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 64. China Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Japan Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 66. Japan Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. South Korea Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 68. South Korea Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. India Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 70. India Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 71. Australia Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 72. Australia Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Taiwan Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 74. Taiwan Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Indonesia Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 76. Indonesia Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Thailand Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 78. Thailand Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 79. Malaysia Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 80. Malaysia Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Philippines Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 82. Philippines Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. Vietnam Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 84. Vietnam Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Asia Pacific Angiogenesis Modulators Market Share by Type in 2019
Figure 86. Asia Pacific Angiogenesis Modulators Market Share by Application in 2019
Figure 87. Latin America Angiogenesis Modulators Sales Growth Rate 2015-2020 (K MT)
Figure 88. Latin America Angiogenesis Modulators Revenue Growth Rate 2015-2020 (US$ Million)
Figure 89. Latin America Angiogenesis Modulators Sales Market Share by Country in 2019
Figure 90. Latin America Angiogenesis Modulators Revenue Market Share by Country in 2019
Figure 91. Mexico Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 92. Mexico Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 93. Brazil Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 94. Brazil Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 95. Argentina Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 96. Argentina Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 97. Latin America Angiogenesis Modulators Market Share by Type in 2019
Figure 98. Latin America Angiogenesis Modulators Market Share by Application in 2019
Figure 99. Middle East and Africa Angiogenesis Modulators Sales Growth Rate 2015-2020 (K MT)
Figure 100. Middle East and Africa Angiogenesis Modulators Revenue Growth Rate 2015-2020 (US$ Million)
Figure 101. Middle East and Africa Angiogenesis Modulators Sales Market Share by Country in 2019
Figure 102. Middle East and Africa Angiogenesis Modulators Revenue Market Share by Country in 2019
Figure 103. Turkey Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 104. Turkey Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 105. Saudi Arabia Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 106. Saudi Arabia Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 107. U.A.E Angiogenesis Modulators Sales Growth Rate (2015-2020) (K MT)
Figure 108. U.A.E Angiogenesis Modulators Revenue Growth Rate (2015-2020) (US$ Million)
Figure 109. Middle East and Africa Angiogenesis Modulators Market Share by Type in 2019
Figure 110. Middle East and Africa Angiogenesis Modulators Market Share by Application in 2019
Figure 111. North America Angiogenesis Modulators Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 112. North America Angiogenesis Modulators Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 113. Europe Angiogenesis Modulators Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 114. Europe Angiogenesis Modulators Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 115. Asia Pacific Angiogenesis Modulators Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 116. Asia Pacific Angiogenesis Modulators Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 117. Latin America Angiogenesis Modulators Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 118. Latin America Angiogenesis Modulators Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 119. Middle East and Africa Angiogenesis Modulators Sales Growth Rate Forecast (2021-2026) (K MT)
Figure 120. Middle East and Africa Angiogenesis Modulators Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 121. Porter's Five Forces Analysis
Figure 122. Channels of Distribution
Figure 123. Distributors Profiles
Figure 124. Bottom-up and Top-down Approaches for This Report
Figure 125. Data Triangulation
Figure 126. Key Executives Interviewed

---